We are live on !
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow % of AUM
Cap. Flow %
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
2.3
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2776
Enhanced Group Inc
ENHA
$167M
| $229K | ﹤0.01% |
+79,840
| New | +$533K |
2026 Q2
0 quarters
|
|
2777
Powerus Corporation Common Stock
PUSA
$277M
| $229K | ﹤0.01% |
+57,314
| New | +$240K |
2026 Q2
0 quarters
|
|
2778
Brinker International
EAT
$8.55B
| $227K | ﹤0.01% |
1,354
-19,272
| -93% | -$2.85M |
2023 Q2
12 quarters
|
|
2779
Encompass Health
EHC
$12.6B
| $225K | ﹤0.01% |
2,227
-295,408
| -99% | -$30.6M |
2025 Q2
4 quarters
|
|
2780
DELISTED
Cross Country Healthcare
CCRN
| $225K | ﹤0.01% |
17,000
-439,996
| -96% | -$5.21M |
2024 Q3
7 quarters
|
|
2781
Infleqtion Inc
INFQ
$1.93B
| $224K | ﹤0.01% |
+16,803
| New | +$231K |
2026 Q2
0 quarters
|
|
2782
BingEx Ltd
FLX
$107M
| $222K | ﹤0.01% |
104,246
+30,496
| +41% | +$74.8K |
2025 Q4
2 quarters
|
|
2783
Neuropace
NPCE
$420M
| $221K | ﹤0.01% |
13,908
-11,543
| -45% | -$186K |
2025 Q4
2 quarters
|
|
2784
Carlsmed
CARL
$366M
| $221K | ﹤0.01% |
+21,283
| New | +$224K |
2026 Q2
0 quarters
|
|
2785
aTyr Pharma
ATYR
$17.1M
| $221K | ﹤0.01% |
368,120
+230,002
| +167% | +$150K |
2026 Q1
1 quarter
|
|
2786
Controladora Vuela Compania de Aviacion
VLRS
$676M
| $220K | ﹤0.01% |
23,518
| – | – |
2020 Q3
23 quarters
|
|
2787
Phinia Inc
PHIN
$2.12B
| $220K | ﹤0.01% |
2,672
-400
| -13% | -$30.6K |
2026 Q1
1 quarter
|
|
2788
iShares Future Exponential Technologies ETF
XT
$3.91B
| $218K | ﹤0.01% |
+2,633
| New | +$206K |
2026 Q2
0 quarters
|
|
2789
Hilton Grand Vacations
HGV
$2.75B
| $217K | ﹤0.01% |
4,147
-95,722
| -96% | -$4.62M |
2025 Q1
5 quarters
|
|
2790
Five Point Holdings
FPH
$312M
| $217K | ﹤0.01% |
41,202
-55,876
| -58% | -$280K |
2024 Q3
7 quarters
|
|
2791
Genco Shipping & Trading
GNK
$1.07B
| $217K | ﹤0.01% |
+8,738
| New | +$211K |
2026 Q2
0 quarters
|
|
2792
Greenland Energy Co
GLND
$136M
| $216K | ﹤0.01% |
+98,119
| New | +$395K |
2026 Q2
0 quarters
|
|
2793
Genesco
GCO
$401M
| $216K | ﹤0.01% |
6,383
-44,913
| -88% | -$1.58M |
2025 Q3
3 quarters
|
|
2794
BKV Corp
BKV
$2.51B
| $215K | ﹤0.01% |
7,867
-115,690
| -94% | -$3.18M |
2026 Q1
1 quarter
|
|
2795
MindWalk Holdings
HYFT
$61.7M
| $215K | ﹤0.01% |
135,967
+110,721
| +439% | +$156K |
2025 Q3
3 quarters
|
|
2796
Gray Television
GTN
$451M
| $214K | ﹤0.01% |
+53,991
| New | +$248K |
2026 Q2
0 quarters
|
|
2797
Lite Strategy Inc
LITS
$35M
| $214K | ﹤0.01% |
232,979
-100,529
| -30% | -$105K |
2025 Q3
3 quarters
|
|
2798
FB Financial Corp
FBK
$2.55B
| $214K | ﹤0.01% |
+3,872
| New | +$208K |
2026 Q2
0 quarters
|
|
2799
Context Therapeutics
CNTX
$22.4M
| $211K | ﹤0.01% |
384,528
-2,563,913
| -87% | -$5.2M |
2025 Q3
3 quarters
|
|
2800
Cardiff Oncology
CRDF
$70.1M
| $211K | ﹤0.01% |
+162,214
| New | +$258K |
2026 Q2
0 quarters
|
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.